The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...
New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
Centers for Disease Control and Prevention. Preventing and treating skin infections. National Psoriasis Foundation. Pustular psoriasis. American Academy of Dermatology. Is that eczema or an ...
Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.
Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease. It means your body thinks its own tissues are foreign invaders to be attacked. With psoriasis ...
Higher cardiovascular health scores on Life’s Essential 8 were linked to a significantly lower risk for psoriasis in a large, ...
Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular PsoriasisVanda expects to immediately begin preparing ...
RB Warren is an NIHR Senior Clinical Lecturer. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback